This article is more than 5 years old. Information may no longer be current.

Meditech Spine receives new indication for Talos interbody devices

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Meditech Spine LLC recently announced it has received FDA clearance for its Talos interbody devices to be used with allograft comprised of cancellous or corticocancellous bone graft.

According to a company press release, all of Meditech’s interbody cervical devices and lumbar devices are now indicated for use with autograft or allograft.

Meditech is the only company with FDA clearance of Invibio’s PEEK-OPTIMA HA Enhanced utilizing autograft or allograft with the Talos-C (HA) cervical interbody devices, according to a press release.

“This continues to build on our platform of products, especially our recently cleared Talos-C (HA) devices that are being adopted by surgeons,” Meditech Spine’s Vice President of Sales Bob Wolownik, said in a press release. “By combining HA with the world’s leading spinal implant material PEEK-OPTIMA Natural and giving surgeons the option of autograft or allograft, we have delivered a game-changing implant.”

Reference:

www.meditechspine.com